Interview: AIPLA President Denise DeFranco

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Interview: AIPLA President Denise DeFranco

DeFranco_Denise_crop_100

Looking back on a whirlwind year: Denise DeFranco reflects on her term as AIPLA President, which included the passage of the Defend Trade Secrets Act and ramping up of the Association's publications



DeFranco-Denise

Denise DeFranco says her year as AIPLA President has been a whirlwind.

"The one thing that I have learned this year is exactly how much AIPLA does for its members and for the IP community as a whole," she says.

"I initially saw the leadership of AIPLA through the lens of the amicus work that the association does, that was my sweet spot and what I really had a passion for. As I have been involved in the leadership, I have learned all of the other things that we do for our members, everything from networking opportunities to education to advocacy in other forums, not just amicus briefs. The list just goes on and on. So in the past year I have really come to appreciate all that the Association has to offer its members and the IP community as a whole."

One goal DeFranco had for the year was to "bring some life to AIPLA's publication efforts." 

She started the Special Committee on Publications to give members a platform for publishing their works. "We have really put into place a process for generating an extensive library of books for our members to learn from but also opportunities for our members to publish," says DeFranco.

This year, in cooperation with Bloomberg BNA, AIPLA published a book titled "Patents After the AIA", and the Association is working on books on design patents, the new trade secrets law, and patents on standards. "We are putting together a good library on a broad range of topics," she says. "I am really pleased with how that is going."

The trade secrets book would be timely, with the Defend Trade Secrets Act (DTSA) signed into law in May.

"AIPLA played our part in helping to work with the Hill in getting something enacted," says DeFranco. "That's something we are really proud of. The DTSA creates a federal civil cause of action for trade secret misappropriation, which has long been needed in our IP jurisprudence. I think AIPLA can be proud of its contribution to help move that forward."

DeFranco says the DTSA is already having an effect.

"I wouldn't say it is necessarily manifesting itself in lawsuits at the moment," she says. "The way it is manifesting itself is that corporations are at this point more seriously considering trade secrets as a viable strong alternative to patent protection. It is becoming a more important part of the complement of IP that is available to corporations. It has always been there, but I think with this federal statute now available it really makes it much stronger."

The year also included a change of job for DeFranco. She left Finnegan to become global head of IP litigation at Johnson & Johnson.



more from across site and SHARED ros bottom lb

More from across our site

Tarun Khurana at Khurana & Khurana says corporates must take the lead if patent filing activity is to truly translate into innovation
Michael Moore, head of legal at Glean AI, discusses how in-house IP teams can use AI while protecting enforceability
Counsel for SEP owners and implementers are keeping an eye on the case, which could help shape patent enforcement strategy for years to come
Jacob Schroeder explains how he and his team secured victory for Promptu in a long-running patent infringement battle with Comcast
After Matthew McConaughey registered trademarks to protect his voice and likeness against AI use, lawyers at Skadden explore the options available for celebrities keen to protect their image
The Via members, represented by Licks Attorneys, target the Chinese company and three local outfits, adding to Brazil’s emergence as a key SEP litigation venue
The firm, which has revealed profits of £990,837, claims it is the disruptive force in the IP-legal industry
In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date
Arun Hill at Clarivate assesses the Top 100 Global Innovators 2026 list, including why AI has assumed a strategic importance for innovation
Practitioners and law firms should keep their eyes peeled for the shortlists for our annual awards
Gift this article